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Mycobacterium tuberculosis (Mtb), the causative
agent of tuberculosis (TB), is an exquisitely adapted
human pathogen capable of surviving for decades in
the lungs of immune-competent individuals in the
absence of disease. The World Health Organization
estimates that 2 billion people have latent TB infec-
tion (LTBI), defined by a positive immunological re-
sponse to Mtb antigens, with no clinical signs of dis-
ease. A better understanding of host and pathogen
determinants of LTBI and subsequent reactivation
would benefit TB control efforts. Animal models of
LTBI have been hampered generally by an inability to
achieve complete bacillary clearance. Herein, we have
characterized a rabbit model of LTBI in which, similar
to most humans, complete clearance of pulmonary
Mtb infection and pathological characteristics occurs
spontaneously. The evidence that Mtb-CDC1551–in-
fected rabbits achieve LTBI, rather than sterilization,
is based on the ability of the bacilli to be reactivated
after immune suppression. These rabbits showed
early activation of T cells and macrophages and an
early peak in the TNF level, which decreased in as-
sociation with clearance of bacilli from the lungs. In
the absence of sustained tumor necrosis factor- pro-
duction, no necrosis was seen in the evolving lung
granulomas. In addition, bacillary control was associ-
ated with down-regulation of several metalloprotease
genes and an absence of lung fibrosis. This model will
be used to characterize molecular markers of protec-
tive immunity and reactivation. (Am J Pathol 2012, 181:
1711–1724; http://dx.doi.org/10.1016/j.ajpath.2012.07.019)Tuberculosis (TB) has been declared a global public
health emergency, accounting for 8.8 million new cases
and 1.1 million deaths among HIV-negative people in
2010.1 In addition to those with known active disease, the
World Health Organization has estimated that 2 billion
people are latently infected with the causative agent,
Mycobacterium tuberculosis (Mtb).2 Individuals with latent
TB infection (LTBI) can experience reactivation, leading
to active infectious TB later in life, and, thus, pose a huge
reservoir of potential new TB cases and additional
sources of Mtb infection. These estimates are based on
immunological tests, in which LTBI is defined as T-cell
recognition of Mtb antigens, determined by either a skin
test reaction to Mtb purified protein derivative (PPD) or an
in vitro interferon gamma blood assay, in the absence of
any clinical signs of disease. However, it is not clear
whether all individuals diagnosed as having LTBI actually
harbor viable Mtb.3 Autopsy studies have confirmed the
presence of viable bacilli in the tissues of individuals who
died of other causes, with no known history of TB, but
these reports are limited.4–6 Although individuals with
LTBI have only a 5% to 10% lifetime risk of reactivating
the infection, the odds are significantly higher with im-
mune compromise, such as that due to HIV infection,
diabetes mellitus, or treatment with immune-suppressive
drugs. Unfortunately, we presently have no means of
identifying which individuals are at greatest risk of reac-
tivating infection. TB control efforts would benefit from a
better understanding of the driving forces leading to es-
tablishment and maintenance of latency and an ability to
predict which individuals are more likely to reactivate
LTBI. Recent studies suggest that LTBI is not a single
manifestation. Rather, they suggest that TB exists as a
spectrum of disease, ranging from the most severe
disseminated forms of disease to classic pulmonary
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AJP November 2012, Vol. 181, No. 5TB, then to subclinical active infection, and, finally, to
true LTBI, in which there are no clinical signs of active
infection or disease.5–7
The outcome of Mtb pulmonary infection is determined
by both host and pathogen factors. In addition to host
immune compromise, several studies have implicated
various genetic polymorphisms in association with resis-
tance or susceptibility to TB in humans.8–11 On the patho-
gen side, numerous studies have demonstrated repro-
ducible differences in virulence and/or immunogenicity
induced by different clinical Mtb strains.12–14 Although
some studies have compared the host response with
large collections of clinical strains, other investigators
have taken a more focused approach, using a limited
number of strains for more in-depth comparative studies.
For example, clinical Mtb strain CDC1551 elicits an early
and robust host immune response in mice and in human
monocytes, compared with the laboratory strain H37Rv
and the clinical strain HN878, a member of the W-Beijing
lineage.15,16 Mtb strain-specific differences in virulence
and immunogenicity have been particularly strikingly
demonstrated in the rabbit TB infection model.17–19 By
using a rabbit model of TB meningitis, we showed that
Mtb CDC1551 infection is more effectively controlled,
resulting in lower bacterial colony-forming units (CFUs) in
the cerebrospinal fluid and brain, with minimal dissemi-
nation to other organs, compared with infection by Mtb
HN878, which causes severe pathological characteris-
tics and more dissemination.20 Similarly, we and others
have shown significant Mtb strain-specific differences in
the ability of rabbits to control bacillary growth and path-
ological characteristics after pulmonary infection. In gen-
eral, although Mtb CDC1551 infection appears to be rel-
atively well controlled, the rabbit is more permissive for
growth and dissemination of Mtb HN878; Mtb H37Rv
infection produces an intermediate response.17,18,21
Several animal models, including mice, guinea pigs,
rats, rabbits, and nonhuman primates, have been used to
study host and bacterial factors that contribute to the
establishment and maintenance of LTBI and reactiva-
tion.22–24 However, none of the published reports from
these models has demonstrated reproducible and com-
plete clearance of culturable bacilli from host tissues.
Even in the nonhuman primate model, considered the
closest to human TB, although approximately 50% of
Mtb-infected animals spontaneously develop LTBI, as
defined by clinical criteria, it is not possible to predict
which animals will control the infection. In addition, sub-
sets of the animals that are defined clinically as latently
infected retain many cultivable Mtb in their lungs, lymph
nodes, or other tissues.25,26 This distinction is important
because, in most reports of human autopsy studies, Mtb
was not directly cultivable from the lungs, but it had to be
identified by either an ability to cause disease in guinea
pigs or PCR determination of Mtb DNA.27
Herein, we have used aerosol infection of rabbits with
Mtb CDC1551 to determine whether spontaneous LTBI
with complete clearance of cultivable bacilli in the lungs
can be established and to evaluate lymphocyte activation
and lung pathogenesis during the infection. Furthermore,
we have immune suppressed infected rabbits by treat-ment with corticosteroid to ascertain that the absence of
cultivable Mtb in the lungs was not sterilization, but true
LTBI.
Materials and Methods
Bacteria and Chemicals
The Mtb CDC1551 strain was obtained from Dr. Thomas
Shinnick at the Centers for Disease Control and Preven-
tion (CDC), Atlanta, GA. The bacterial inoculum for infec-
tion was prepared by growing the bacilli in Middlebrook
7H9 medium with 10% oleic acid albumin dextrose cat-
alase enrichment (Difco BD, Franklin Lakes, NJ). Stock
cultures were banked frozen at 80°C and thawed just
before use, as previously described.28 All chemicals
were obtained from Sigma-Aldrich (St Louis, MO), unless
otherwise mentioned.
Rabbit Infection and Treatment
Specific pathogen-free, female, New Zealand white rab-
bits (Oryctolagus cuniculus), weighing 2.2 to 2.6 kg, were
used (n  91) for aerosol infection by Mtb CDC1551 in
four separate experiments (n  2 to 4 per time point per
experiment), as previously described.29 Briefly, rabbits
were exposed to Mtb-containing aerosol using a nose-
only delivery system. At 3 hours after exposure, a group
(n  4) of rabbits was euthanized, and serial dilutions of
the lung homogenates were cultured on Middlebrook
7H11 (Difco BD, Franklin Lakes, NJ) agar plates to enu-
merate the number of initial (time  0) bacterial CFUs
implanted in the lungs. At 2, 4, 8, 12, 20, 24, and 26
weeks after infection (p.i.), groups of rabbits (n  2 to 4)
were euthanized and lung, liver, and spleen tissues were
harvested for CFU assay, histological analysis, single-cell
suspension, and total RNA isolation. Approximately 25%
(by weight) of the entire lung, 5% of the liver (in grams),
and approximately 50% of the spleen were sampled ran-
domly from different areas of each organ to prepare
homogenates for the CFU assay. Undiluted and serially
diluted homogenates were placed on Middlebrook 7H11
medium supplemented with 10% oleic acid albumin dex-
trose catalase enrichment (Difco BD). Starting at 20
weeks p.i., a group of infected rabbits was treated by i.m.
injection with triamcinolone at 16 mg/kg body weight
daily for 5 days per week for 4 weeks, followed by resting
for 2 additional weeks. At 24 and 26 weeks p.i., triamcin-
olone-treated and triamcinolone-untreated rabbits (n 2 to
3) were euthanized; tissue samples were prepared as pre-
viously described. Lung tissues for RNA isolation were snap
frozen at 80°C immediately after removal. All animal pro-
cedures, including Mtb infection, p.i. housing, necropsy,
and processing of infected tissues, were performed in bio-
safety level 3 facilities, per the approved procedures by the
Institutional Animal Care and Use Committee of the Univer-
sity of Medicine and Dentistry of New Jersey, Newark. The
animals were fed with food and water ad libitum.
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Portions of lung tissue fromMtb-infected and triamcinolone-
treated or triamcinolone-untreated rabbits were fixed in
10% formalin solution, paraffin embedded, and cut into
sections (5 m thick) for staining with H&E to visualize the
organization and distribution of leukocytes. One-step
trichrome (Gomori) staining was performed on sections to
visualize collagen and elastin fibers, as previously re-
ported.29 The stained sections were analyzed using a
Nikon DXM 1200C microscope and photographed at
10 or 40 magnification using NIS-Elements F3.0 soft-
ware (Nikon Instruments Inc., Melville, NY).
Flow Cytometry Analysis
Single-cell suspensions from Mtb CDC1551-infected rab-
bit lungs and spleens were prepared and used in flow
cytometry analysis, as previously described.30 Briefly,
lung and spleen slices were minced and lung homoge-
nates were digested with collagenase treatment. After
incubation with DNase I, the homogenates were passed
through a strainer to collect the cells. The erythrocytes
were removed by ACK lysis solution (erythrocyte lysing
buffer) treatment. The cells were washed thoroughly and
stained with trypan blue to determine the viability before
use in functional assays. For flow cytometric analysis,
purified rabbit lung cells were stained with fluorescein
isothiocyanate–conjugated anti-rabbit CD4, phosphati-
dylethanolamine-conjugated anti-rabbit CD8, or fluores-
cein isothiocyanate–conjugated anti-rabbit IgG (AbD Se-
rotec Inc., Raleigh, NC) and biotinylated anti-rabbit IgM
antibodies (BD Pharmingen, San Diego, CA), followed by
avidin-phosphatidylethanolamine for surface staining.
The staining for CD14 cells and for intracellular tumor
necrosis factor (TNF)- was performed with Alexa 647–
conjugated anti-human CD14, followed by incubation
with biotinylated anti-human TNF- and avidin-phosphati-
dylethanolamine. The labeled cells were analyzed using
a BD FACS Calibur flow cytometer (BD Biosciences, San
Jose, CA) and FlowJo software (Tree Star, Ashland, OR).
For the T-cell proliferation assay, purified rabbit spleen
cells were stained with carboxyfluorescein succinimidyl
ester dye (CFSE), per the manufacturer’s guidelines (Life
Technologies, Grand Island, NY), and stimulated with
either heat-killed and sonicated Mtb CDC1551 or PPD
(Staten Serum Institute, Copenhagen, Denmark) or left
unstimulated. The cells were stained with either anti-rab-
bit CD4 or CD8 monoclonal antibodies (BD Biosciences),
followed by allophycocyanin-conjugated anti-mouse IgG.
The stained cells were acquired using a BD FACS Calibur
flow cytometer (BD Biosciences), and the data were an-
alyzed with FlowJo software (Tree Star).
Measurement of Serum Anti-PPD IgG
The amount of circulating IgG in the serum of Mtb
CDC1551-infected rabbits was determined as previously
reported.30 Briefly, 96-well plates (Corning Inc., Corning,
NY) were coated with PPD and incubated with rabbit
serum, followed by primary rabbit anti-PPD polyclonalantibody (Antibodies-Online GmbH, Atlanta). After thor-
ough washings, the wells were incubated with alkaline
phosphate–conjugated goat anti-rabbit IgG secondary
antibody (Southern Biotech, Birmingham, AL). The alka-
line phosphate activity was measured by using Sigma
Fast solution, per the instructions of the manufacturer
(Sigma-Aldrich, St. Louis, MO). The actual serum IgG
amounts were derived from the reference standard of
known concentration, run in parallel with the test sam-
ples.
Rabbit Lung Total RNA Isolation
Total host RNA from the lungs of Mtb-infected rabbits
(n  3) and matched uninfected control animals (n  5)
at various time points (3 hours and 2, 4, 8, and 12 weeks
p.i.) was isolated, as previously described.31 Briefly, por-
tions of frozen lung tissue were thawed in the presence of
10 volume (w/v) of TRIzol reagent (Life Technologies)
and homogenized on ice. The homogenate was ex-
tracted with 0.3 volumes (v/v) of chloroform, and the
aqueous phase, containing RNA, was passed through
mini spin columns from the NucleoSpin RNA II kit (Mach-
erey-Nagel, Duran, Germany). On-column digestion of
the contaminating DNA using DNase I, followed by puri-
fication, was performed, as described by the manufac-
turer. The quality and quantity of the purified RNA were
assessed by formaldehyde–agarose gel electrophoresis
and a NanoDrop instrument (NanoDrop Products, Wil-
mington, DE), as previously described.32
Microarray Analysis of Rabbit Gene Expression
Total RNA extracted from uninfected and Mtb CDC1551-
infected rabbit lungs at 3 hours and 2, 4, 8, and 12 weeks
p.i. was used for the microarray experiments, as previ-
ously described.31 Total RNA from individual, Mtb-in-
fected animals was processed separately, and RNA
samples from uninfected animals were pooled for mi-
croarray analysis. Rabbit whole genome microarray
slide and reagents were obtained from Agilent Tech-
nologies, Inc. (Santa Clara, CA), and used per the
recommendations of the manufacturer. Briefly, total
lung RNA from uninfected and Mtb CDC1551-infected
rabbits was reverse transcribed and labeled with Cy3
(uninfected) or Cy5 (Mtb-infected) dyes, respectively.
The dye incorporation and bias during labeling of
cDNA was assessed by a NanoDrop instrument
(NanoDrop Products). Equimolar amounts of Cy3- and
Cy5-labeled cDNA were mixed and hybridized to the
rabbit microarray slides. The slides were processed
and spots were scanned, and the Cy3 and Cy5 inten-
sity data were acquired after adjustment for back-
ground signals using Agilent Feature Extraction soft-
ware (Agilent Technologies, Inc.), as previously
described.31 Three microarrays were used for each of
the experimental time points using separate RNA sam-
ples from two to three animals at 3 hours and 2, 4, 8,
and 12 weeks p.i. The extracted raw microarray data
were subjected to further statistical analysis using
Partek Genomics Suite software, version 6.5 (Partek
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ferentially expressed genes, we used P value of signif-
icance from two-way analysis of variance. P  0.05
was considered statistically significant. We previously
showed that selection of genes using P values, rather
than arbitrary expression level as cutoff values,
enriches for genes that are functionally more sig-
nificant.30 The microarray data have been submit-
ted to Gene Express Omnibus (http://www.ncbi.nlm.nih.
gov/geo; accession number GSE39219).
Pathway Analysis of Differentially Expressed
Rabbit Genes
The differentially expressed rabbit genes that are statis-
tically significant (P  0.05) and annotated were up-
loaded to Ingenuity Pathway Analysis (IPA) software (In-
genuity Systems, Redwood City, CA) for further analysis,
as previously reported.31 Because the IPA knowledge
base does not have rabbit gene information, we used the
cumulative functional orthologous data from human,
mouse, and rat genomes for the pathway analysis and
network derivation. In IPA, the significance of a functional
pathway/network composed of differentially expressed
genes is determined by the P value calculated using the
right-tailed Fisher’s exact test.
Real-Time qPCR Analysis
Total RNA from uninfected and Mtb-infected rabbit lungs
at 3 hours and 2, 4, 8, and 12 weeks p.i. was reverse
transcribed into cDNA using the AffinityScript QPCR cDNA
Table 1. Description of Target Genes and Oligonucleotide Prime
Gene Primer Sequence
TLR2 Forward 5=-CTCTCGCAGAACTTCGTCAA-
Reverse 5=-AGAATGGCGGCGTCGTTGTT-
TNF Forward 5=-CTGAGTGACGAGCCTCTAGC-
Reverse 5=-TTCATGCCGTTGGCCAGCAG-
CD14 Forward 5=-GCTATGCTGACGTAGTCAAG-
Reverse 5=-GGTGCCAGTTACCTCTATGT-
CAV1 Forward 5=-GCGACCCCAAGCATCTCA-3=
Reverse 5=-GATGGTAGACAGTAGGCG-3=
NP4 Forward 5=-TGGACGTGGCCGTCTACATT-
Reverse 5=-TGTGGCGGACTCCATTGACT-
VCAM1 Forward 5=-CTGGAGGATGCAGGAGTGTA-
Reverse 5=-GAGCACGAGAAGTTCAGG-3=
LGALS3 Forward 5=-AGGGAAGAAAGGCAGACGAC-
Reverse 5=-CATCATTGACCGCAACCTTG-
PRKC Forward 5=-CCATCGGTCTGTTCTTCCTA-
Reverse 5=-GTCAGCGATCTTGATGTGTC-
MMP9 Forward 5=-CGCCAGCTACGACAAGGACA-
Reverse 5=-AAGTGGTGGCACACCAGAGG-
MMP12 Forward 5=-CCAACTGGCTGTGACCACAA-
Reverse 5=-AGCAGCCTCAATGCCTGAAG-
MMP14 Forward 5=-CCACAAGATGCCTCCTCAAC-
Reverse 5=-GTAGCCGTCCATCACTTGGT-
TIMP1 Forward 5=-AGACGGCCTTCTGCAACTCC-
Reverse 5=-AACTCCTCGCTGCGGTTCTG-
GAPDH Forward 5=-GGCGTGAACCACGAGAAGTA-
Reverse 5=-TCCACAATGCCGAAGTGGTC-
MMP, matrix metalloproteinases.Synthesis Kit, following the instructions of the manufacturer(Agilent Technologies, Inc.). The quantitative (q)PCR exper-
iments were performed on a Stratagene Mx3005p machine
(Agilent Technologies, Inc.) with cDNA and site-specific
oligonucleotide primers of target genes, using Brilliant III
Ultra-Fast SYBR Green QPCR Master Mix, according to
the product instructions (Agilent Technologies, Inc.). The
inert, passive reference dye, ROX, was added to all of
the test samples. No SYBR Green and no cDNA control
samples were included in one of the triplicate assays for
each experimental time point. The housekeeping gene,
GAPDH, was included to normalize the levels of expres-
sion of test samples. The amplicon sizes of GAPDH and
test genes were between 90 and 250 bp. The CT value
was determined using MxPro4000 software (Agilent
Technologies, Inc.) after setting uniform baseline fluores-
cence for all of the samples in each experiment. The fold
change in gene expression was calculated from the for-
mula, 2-CT, in which CT is the difference in CT be-
tween the test gene and GAPDH. Each experiment was
repeated at least three times with cDNA from two to four
animals per experimental time point per group. Table 1
contains a description of the tested genes, their acces-
sion numbers, and the DNA sequence of primers used in
the qPCR experiments.
Statistical Analysis
The rabbit microarray data were analyzed by analysis of
variance using Partek Genomics Suite software, version
6.5 (Partek Inc.), and the significance of the functional
pathway/network was determined by Fisher’s exact test
using IPA (Ingenuity Systems). An independent Student’s
d in this Study
Description Gene ID
Toll-like receptor-2 100009578
TNF- 100009088
Monocyte differentiation antigen 100008983
Caveolin 1 100008837
Microbicidal peptide-beutrophil
proteinase-4
100009135
Vascular cell adhesion
molecule-1
100008901
Galactose- binding lectin, 3 100009187
Protein kinase C 100037719
MMP-9 NM_001082203.1
MMP-12 NM_001082771.1
MMP-14 NM_001082793.1
Tissue inhibitor of
metalloproteinase-1
100009047
Glyceraldehyde 3-phosphase
dehydrogenase
100009074rs Use
3=
3=
3=
3=
3=
3=
3=
3=
3=
3=
3=
3=
3=
3=
3=
3=
3=
3=
3=
3=
3=
3=
3=t-test from GraphPad Prism software, version 5.02
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analysis of flow cytometry and qPCR data, and the
mean  SD or median  SE values, respectively, were
plotted. For all of the experiments, P  0.05 was consid-
ered statistically significant.
Results
Growth of Mtb CDC1551 in Infected Rabbits
After infection of rabbits with Mtb CDC1551, the growth
kinetics were evaluated by measuring the number of
CFUs in various organs of the rabbits. In the lungs, Mtb
CDC1551 grew exponentially from 3.5 log10 at expo-
sure (time  3 hours) to approximately 5 log10 at 4
weeks p.i. Thereafter, the numbers of CFUs declined
gradually. By 12 weeks, no cultivable bacteria were
found in the lungs of some of the rabbits (approxi-
mately 30%), whereas the others still had detectable
CFUs (Figure 1, A and B). By 20 weeks, all rabbits had
no detectable CFUs in the lungs. No CFUs were found
in the livers or spleens of the infected rabbits at any of
the tested time points (data not shown). This pattern of
active bacillary growth up to 4 weeks, followed by a
gradual reduction in CFUs and complete clearance of
cultivable bacilli from the lungs, was similar for a range
of initial bacillary loads. However, the time to complete
clearance of the CFUs differed, depending on the ex-
act infectious dose, so that a higher initial bacillary
load took a longer time to clear. After infection with 4
log10, approximately 30% of rabbits cleared the infec-
tion by 20 weeks, and all cleared the infection by 24
weeks, p.i. (Figure 1B). More important, bacillary clear-
ance was not the result of sterilization of the infection,
as demonstrated by our ability to reactivate the infec-
tion by immune suppression of rabbits at 20 weeks p.i.
Four weeks of treatment with the corticosteroid, triam-
cinolone, resulted in resumed bacterial growth and a
consistent increase in CFUs in the lungs. At the end of
triamcinolone treatment (24 weeks), approximately 4.7
log10 CFUs were measured in the lungs; the bacillary
load remained stable (from 24 to 26 weeks) after the
drug treatment was discontinued (Figure 1A). At 24
and 26 weeks p.i., 8 of 8 and 8 of 9 rabbits, respec-
tively, had no detectable CFUs in the lungs. Thus,
among the rabbits infected for 20 weeks, spontane-
ous reactivation or persistence was seen in only 1 of 17
infected rabbits (described later).
Pathological and Histopathological
Characteristics in Mtb CDC1551-Infected
Rabbit Lungs
Examination findings of the lungs of Mtb CDC1551-in-
fected rabbits showed no macroscopic lesions from 2 to
12 weeks p.i. (see Supplemental Figure S1 at http://
ajp.amjpathol.org). In only 1 of 17 infected animals, a
single macroscopic subpleural granuloma was visible at
20 weeks p.i. (described later). In contrast, H&E stainingof the lung sections, followed by a histological examina-
tion, revealed multiple microscopic lesions in the lungs of
all rabbits from 4 to 12 weeks p.i. (Figure 1, C and D; see
also Supplemental Figure S1 at http://ajp.amjpathol.org).
Granulomatous foci, seen at 4 weeks, had small aggre-
gates of macrophages and lymphocytes. Granulomas
enlarged into well-organized structures with more cells at
Figure 1. Lung bacillary load and histopathological characteristics during
Mtb CDC1551 infection of rabbits. A: Kinetics of Mtb growth in the infected
lungs of untreated and triamcinolone (immune suppression) treated rabbits.
Complete clearance of cultivable bacilli is noted at 20 weeks p.i.; 4 weeks of
triamcinolone treatment (arrow) resumed bacillary growth in the infected
rabbit lungs. B: Kinetics of bacillary growth and clearance in the lungs of
rabbits infected with a low or high dose of Mtb CDC1551. No bacterial CFUs
are obtained in the rabbit lungs after 12 or 24 weeks in the low- and
high-dose infections, respectively. Values are given as mean  SD, obtained
from 91 rabbits in four separate experiments, with four to five animals per
time point (A and B). C–H: Histopathological characteristics of rabbit lungs
infected with Mtb CDC1551. C and D: Lungs of infected, untreated rabbits at
8 weeks p.i., showing well-organized granulomas containing aggregates of
mononuclear cells (arrows) surrounded by a lymphocytic cuff. E and F: Mtb
CDC1551-infected rabbit lungs at 24 weeks p.i., without triamcinolone treat-
ment. In both E and F, almost normal lung parenchyma and alveoli with
moderately elevated cellularity can be seen. G and H: Histological charac-
teristics of Mtb-infected rabbit lungs, treated with triamcinolone for 4 weeks,
initiated at 20 weeks p.i. Large suppurative infiltration with many macro-
phages and polymorphonuclear leukocytes (arrows) that contain red gran-
ules in their cytoplasm are seen. Scale bars: 100 m (C, E, and G); 50 m (D,
F, and H). All sections were stained with H&E and photographed. Original
magnification: 10 (C, E, and G); 40 (D, F, and H).8 weeks. No necrosis or caseation was observed in any
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sorb, becoming smaller and less cellular (see Supple-
mental Figure S1 at http://ajp.amjpathol.org). By 20 and
24 weeks p.i., the lung parenchyma and alveoli displayed
mildly elevated cellularity, with no intact granulomas and
minimal signs of tissue damage or fibrosis (Figure 1, E
and F; see also Supplemental Figure S1 at http://ajp.
amjpathol.org). In contrast, the lung sections of infected
rabbits treated for 4 weeks with triamcinolone (from 20 to
24 weeks) showed large suppurative diffuse infiltration of
immune cells, composed primarily of macrophages and
polymorphonuclear leukocytes (Figure 1, G and H). Thus,
the histopathological profile correlated with the lung bac-
terial load. The increase in bacterial CFUs, followed by a
gradual containment of the bacterial growth and com-
plete clearance over time, was associated with an initial
cellular response, followed by resolution of lung patho-
logical characteristics as the CFUs declined. The in-
creased bacterial CFUs seen in the infected rabbits on
immune suppression–induced reactivation was accom-
panied by renewed recruitment of leukocytes into the
lungs.
Interestingly, as previously mentioned, at 20 weeks
p.i., 1 of 17 Mtb CDC1551-infected rabbits had a single,
visible, subpleural unresolved lesion in the right lower
lobe of the lungs (Figure 2A). The results of a histological
examination of this lesion showed a large cellular granu-
loma with a central area of epithelioid macrophages sur-
rounded by a prominent lymphocytic cuff (Figure 2, B
and C). When cultured for bacteria, the lesion contained
a bacillary load of approximately 2.8 log10 CFUs (see
Supplemental Table S1 at http://ajp.amjpathol.org). In
contrast, other areas of the lung of this rabbit (seven
different samples) had no detectable CFUs and no visible
granulomas. Similarly, in one rabbit infected for 26
weeks, residual infection (Mtb CFU) was found in one
focused area in the right lung, which was not evaluated
for pathological characteristics (data not shown).
Mononuclear Cellular Composition in the Mtb
CDC1551-Infected Rabbit Lungs
The distributions of mononuclear leukocyte populations
in single-cell suspensions prepared from infected rabbit
lungs (n  4 to 5 per time point) were determined by flow
cytometry (Table 2). Of the total mononuclear cell popu-
lation isolated from the infected rabbit lungs, an increase
in the percentage of nonlymphocyte mononuclear cells
was observed from 4 to 8 weeks, which was maintained
at similar levels at 12 weeks. Among the total lymphocyte
populations, the percentages of CD4 and CD8 cells
were relatively low at 4 weeks and peaked at 8 weeks p.i.
(Table 2). A strikingly high percentage of the total lym-
phocyte population was B cells (70%). However, the
anti-IgG antibodies used to identify B cells may have also
bound to Fc receptors expressed on the surface of other
cell types, leading to an overestimation of this cell pop-
ulation. Since anti-IgG staining was not seen in the mac-
rophages, which express high levels of Fc receptors, but
only in the lymphocyte population, it was likely that theFigure 2. Gross pathological and histological characteristics of Mtb
CDC1551-infected rabbit lung harboring a persistent or spontaneously
reactivated (percolator) granuloma at 20 weeks of infection. A: A single
subpleural lesion is clearly visible in the bottom right lobe of the lung
(box and inset) obtained from one of the Mtb-infected rabbits without the
immune-suppression treatment. B and C: Histological staining of the lung
with percolator granuloma showing a large, coalescent granulomatous
lesion with an area of epithelioid macrophages, surrounded by a lympho-
cytic cuff (arrows). Scale bars: 100 m (B); 50 m (C). The tissue sections
were stained with H&E and photographed. Original magnification: 10
(B); 40 (C).
tion.
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linked immunosorbent assay, we measured the anti-
PPD-IgG levels in the serum of CDC1551-infected rab-
bits.30 Surprisingly, there was only a limited increase in
the levels of serum IgG as the infection progressed
from 4 to 12 weeks. The increase was not statistically
significant compared with the baseline values (3 hours
p.i.) (Table 2).
Spleen T-Cell Activation during Mtb CDC1551
Infection
The activation of host T cells was evaluated after infection
with Mtb CDC1551 (Figure 3). To enumerate the popula-
Figure 3. Flow cytometry analysis of spleen T-cell proliferation in Mtb
CDC1551-infected rabbits. A and B: The percentage of proliferating spleen
CD4 T cells cultured with PPD or Mtb or unstimulated. In B, the statistically
significant differences between various stimulants at different time points
after infection are denoted by either a single asterisk (compared with a
previous experimental time point; P 0.05) or a double asterisk (compared
with unstimulated conditions; P  0.05). C and D: The percentage of pro-
liferating spleen CD8 T cells cultured with PPD or Mtb or unstimulated. In D,
the statistically significant differences between various stimulants at different
time points after infection are denoted by either a single asterisk (compared
with 8 weeks p.i.; P  0.05) or a double asterisk (compared with unstimu-
lated and PPD- or Mtb-stimulated conditions; P  0.05). The color code in A
and C corresponds to proliferation of cells stimulated with concanavalin A
(red), PPD (light blue), or Mtb (green), unstimulated cells (orange), and cells
Table 2. Immune Cell Composition in Mtb CDC1551-Infected Ra
Time p.i. (weeks) Nonlymphocyte mononuclear cells* Ly
4 32.8  4.6
8 72.2  2.9
12 64.1  7.4
Data are given as mean  SD. The percentages of cells in single-ce
*Data are given as percentage of total mononuclear cell population.
†Data are given as percentage of total lymphocyte gated cell popula
‡IgG levels are expressed as ng/L on a log10 scale. The IgG valuewith no CFSE (dark blue). Values plotted in the graph are mean  SD,
measured in samples from at least three animals.tions of antigen-specific proliferating CD4 and CD8 T
cells, single-cell suspensions of the spleen from infected
rabbits (n  4 to 5 per time point) were labeled with
CFSE. Cells were stimulated with either PPD or heat-killed
sonicated Mtb CDC1551, and the percentages of prolif-
erating T lymphocytes were determined by the dilution of
CFSE and compared with the labeled, but unstimulated,
cells using flow cytometry (Figure 3). At 4 weeks, the
percentage of proliferating CD4 cells had increased in
the PPD (79.5 2.7) and Mtb (78.1 3.2) stimulated and
unstimulated (66.5  7.1) cells. The differences between
the stimulated and unstimulated groups were not statis-
tically significant. By 8 weeks, the percentage of prolifer-
ating CD4 cells was significantly reduced (P  0.05) in
all three stimulation groups (Figure 3, A and B). At this
time, significantly more (P  0.05) proliferating CD4
cells were observed in response to PPD (50.4  0.9) and
Mtb (34.5  4.4) stimulation compared with the unstimu-
lated cells (16.3  3.4). PPD induced significantly (P 
0.001) more proliferating CD4 cells compared with Mtb
stimulation. At 12 weeks, the percentage of CD4 cells
proliferating in response to PPD (51.7  28.3) and Mtb
(52  27.6) stimulation was comparable and significantly
higher than the unstimulated (19.9  7.1) cells (Figure
3B). By 20 weeks, the percentage of proliferating CD4
cells had declined significantly (P 0.05) compared with
12 weeks for both PPD (19.3  2.7) and Mtb (15.2  4.3)
stimulation. The percentage of CD4 cell proliferation
further declined significantly by 24 weeks (P  0.05) in
the PPD-stimulated group (6.7  1.9) but not in the Mtb-
stimulated group (11.5  4.5). The percentage of prolif-
erating unstimulated cells remained similarly low from 8
to 24 weeks of infection.
In contrast to the CD4 cells, the percentage of pro-
liferating CD8 cells increased from 4 weeks to reach a
maximum at 8 weeks in response to both PPD and Mtb
stimulation (Figure 3, C and D). Although there was no
significant difference in the percentage of proliferating
CD8 cells among the PPD (70.8 9.6) or Mtb (73 8.9)
stimulated and unstimulated (50.7  13.8) cells at 4
weeks, CD8 cell proliferation was significantly in-
creased (P  0.005) in response to Mtb (87.1  0.8) and
PPD (91.6  1) stimulation compared with unstimulated
cells (56.7  3.2) at 8 weeks (Figure 3D). At 12 weeks,
the percentage of proliferating CD8 cells in the PPD
(63.5  26.5) and Mtb (67.9  23.3) stimulated groups
had decreased to the level seen in the unstimulated cells
(54.8  23.2). As observed for the CD4 cells, the per-
centage of proliferating CD8 cells was reduced signifi-
ngs
ytes* CD4† CD8† B cells† Serum IgG‡
4.7 3.4  0.5 3.9  2.0 79.3  6.3 2.0  0.8
3.0 19.1  1.5 6.1  0.6 73.7  4.0 3.2  0.8
7.4 3.4  0.6 2.0  0.5 86.1  2.4 3.0  0.6
nsions were identified by immunostaining and flow cytometry.
line (3 hours after infection) was 2.0  0.2.bbit Lu
mphoc
66.7 
27.3 
35.7 
ll suspecantly (P  0.01) at 20 and 24 weeks p.i. in the PPD
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AJP November 2012, Vol. 181, No. 5(18.1 1 and 19.7 9.6, respectively) or Mtb (13.4 1.2
and 18.6  10.9, respectively) stimulated and unstimu-
lated (10.16 5.5 and 8.4 5.5, respectively) conditions
(Figure 3D). Taken together, these results suggested a
strong and rapid activation and proliferation of T cells at
4 and/or 8 weeks in the Mtb CDC1551-infected rabbits,
which then declined as the antigenic load was reduced.
Macrophage Activation in the Lungs and Spleen
during Mtb CDC1551 Infection
To determine the proportion of activated macrophages,
single-cell suspensions were prepared from infected rab-
bit lungs and spleens at 4, 8, and 12 weeks, and the cells
were stained for CD14 and intracellular TNF-. The per-
centage of CD14 cells and CD14TNF- was enumer-
ated by flow cytometry. The percentage of CD14 cells in
the lungs increased from 4 weeks (38.6%) to 8 weeks
(58.2%) and then declined at 12 weeks p.i. (15%). In the
spleen, CD14 cell populations were relatively high at 4
weeks (25.1%), then declined by 8 weeks (12.9%), and
stabilized at comparable levels up to 12 weeks p.i. (Table
3). The percentage of CD14 cells that expressed TNF-
increased in the lungs from 10.5% to 38.4% between 4
and 8 weeks and declined to 7.8% at 12 weeks p.i.
Similarly, in the spleen, the percentage of CD14TNF-
cells increased significantly from 9.1% at 4 weeks to
15.5% at 8 weeks, followed by a decline at 12 weeks
(6.8%) (Table 3). Thus, in the Mtb CDC1551-infected
rabbits, peak macrophage activation, as determined by
intracellular TNF- staining, occurred at 8 weeks in both
the lungs and the spleen and declined as the bacillary
load was reduced.
Transcriptional Analysis of Selected Cellular
Pathway Genes in Rabbit Lungs during Mtb
CDC1551 Infection
Because both the granulomatous response and macro-
phage activation in the lungs of CDC1551-infected rab-
bits peaked and then declined as the bacillary load was
cleared, we examined whether inflammation and fibrosis/
tissue remodeling followed a similar pattern of expression
in infected rabbit lungs. Whole genome microarray was
used to analyze the transcription profile of selected net-
works associated with pathogenesis induced in Mtb
CDC1551-infected rabbit lungs at 2, 4, 8, and 12 weeks
Table 3. Distribution of Activated Macrophages in the Mtb CDC1
Time p.i. (weeks)
Lung
CD14* CD14
4 38.6  11 10
8 58.2  4 38
12 15.0  2 7
Data are given as mean  SD percentages of cells stained in single-
*Data are given as percentage of total mononuclear cell population.
†Data are given as percentage of total CD14 gated cell population.p.i. and compared with the expression levels in unin-fected animals. The microarray data have been submit-
ted to Gene Express Omnibus (accession number
GSE39219). Significantly differentially expressed genes
were selected based on P  0.05 and used in selected
pathway analysis and network derivation. The transcript
level of genes involved in inflammation and fibrosis/tissue
modeling networks was used for network construction
using IPA software (Figure 4). Of the 25 genes in the
inflammation network, 21 were significantly differentially
expressed at 2 weeks compared with uninfected lungs (8
were increased, and 13 were decreased) (Figure 4, A
and B). The number of up-regulated genes decreased at
4, 8, and 12 weeks to six, five, and two genes, respec-
tively. In addition, the number of down-regulated genes
increased from 13 at 2 weeks to 16, 18, and 15 at 4, 8,
and 12 weeks, respectively. In addition to TNF, expres-
sion of NR3C1, HLA-C, TLR2, HPX, NOS2, SLC10A2, and
FTL were significantly up-regulated at 2 weeks, whereas
genes encoding cytokines/chemokines (IL15, CSF2,
IL1B, CCL2, and IL8), cell surface molecules (CD1D,
TNFSF13B, TLR3, and VCAM1), enzymes (ARG2, PTGS2,
and F3), and a transcriptional regulator (SMAD4) were
down-regulated at this time. By 12 weeks p.i., only
NR3C1 and TLR2 remained up-regulated, whereas most
of the other genes, including TNF, were significantly
down-regulated compared with uninfected lungs. Tran-
script levels of CD1D, IL15, SMAD4, and TLR3 were tran-
siently up-regulated from 2 to 4 and/or 8 weeks and then
down-regulated again (Figure 4A). Overall, the expres-
sion pattern of genes suggested a moderate up-regula-
tion of the inflammation network at 2 weeks, which then
declined as the infection and bacterial burden decreased
in the lungs.
Of the 25 genes in the tissue fibrosis and remodeling
network, the number of significantly up-regulated genes
gradually decreased from 2 (14 genes) to 4 (11 genes),
to 8 (8 genes), and to 12 (3 genes) weeks p.i. (Figure 4,
C and D). In contrast, the number of down-regulated
genes increased from 7 (2 weeks) to 10 (4 weeks), to 13
(8 weeks), and to 12 (12 weeks). Only TIMP1 and PRKCB
were up-regulated from 2 to 12 weeks, whereas IFNG,
TNNT2, PLAU, VTN, ELANE, and AHR expression was
sustained from 2 to 4 or 8 weeks and then declined
(Figure 4C). FAS, IL4, and CAV1 increased transiently
and then declined.MMP14,MMP13,MMP9, andMMP12
were down-regulated to varying degrees at all time
points. Taken together, the expression pattern of fibrosis
and tissue remodeling network genes suggested a tran-
fected Rabbits
Spleen
-† CD14* CD14 TNF-†
.4 25.1  11 9.1  2.0
.1 12.9  1.0 15.5  3.9
.0 10.0  1.4 6.8  0.2
pensions.551-In
 TNF
.5  1
.4  1
.8  1
cell sussient activation of this network in the Mtb CDC1551-in-
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as the bacilli cleared and the granulomas resorbed.
To validate the microarray results and to analyze the
expression of inflammation and fibrosis/tissue remod-
eling genes in the lungs of infected rabbits, we mea-
sured the transcript levels of selected genes at 2, 4, 8,
and 12 weeks using real-time quantitative PCR (qPCR)
and compared them with corresponding levels in un-
infected animals (Figure 5). The list of selected genes
involved in these pathways includes TLR2, TNF,
CD14, CAV1, NP4, VCAM1, LGAL, PRKC, MMP9,
MMP12, MMP14, and TIMP1. The expression pattern of
most of the selected inflammatory genes and all of the
fibrosis/tissue remodeling genes was consistent with
the microarray results. Compared with uninfected rab-
bit lungs, the expression of CD14 was moderately up-
regulated at all time points. Transcription of a defensin
(NP4) was up-regulated 10-fold in the rabbit lungs at
2 weeks, and remained elevated up to 12 weeks. TNF
transcript levels were transiently, but significantly, up-
regulated at 2 weeks, whereas VCAM1 was down-reg-
ulated from 2 until 12 weeks p.i. Similarly, except for
TIMP1 and PRKC, the selected genes in the fibrosis/
tissue remodeling network were predominantly down-
regulated at all time points (Figure 5). Overall, consis-
tent with the microarray analysis, these results
suggested an early transient macrophage activation/
inflammation (2 weeks) and complete down-regulation
of the tissue fibrosis/remodeling network at later times
of infection.
Lung Fibrosis in the Mtb CDC1551-Infected
Rabbits
The results from transcriptional analysis suggested that
macrophage activation/inflammation and fibrosis/tissue
remodeling pathways are transiently activated but not
chronically induced in the rabbit lungs in response to Mtb
CDC1551 infection. To determine the corresponding al-
terations in the pathological characteristics during the
infection, lung sections were stained by Gomori trichrome
and analyzed microscopically for collagen deposition,
fibrosis, and tissue remodeling (Figure 6). Despite the
formation of a clearly demarcated cellular granuloma,
with central areas of macrophages and peripheral lym-
phocytic cuffs, only moderate compression of the lung
tissue surrounding the granuloma was noted at 12 weeks
p.i. (Figure 6A). The absence of fibrosis, which is typical
of progressive TB, was striking (Figure 6, B and C). The
background staining for collagen observed in the lung
tissue adjacent to the granulomas (Figure 6C) was similar
to that seen in uninvolved areas of the lung (Figure 6, A
and B). No significant collagen staining and fibrosis were
observed in the lung granulomas at any of the other
tested time points (data not shown). This was in stark
contrast to the highly fibrotic lesions seen when rabbits
were infected for 12 to 16 weeks with Mtb HN878, which
led to chronic granulomatous disease rather than latency
in the animals.29Discussion
We have characterized a model of LTBI in rabbits in
which, similar to 90% of immune-competent humans,
complete clearance of pulmonary Mtb infection and path-
ological characteristics occurs spontaneously. The evi-
dence that Mtb CDC1551-infected rabbits achieved
LTBI, rather than sterilization, is based, as in humans, on
the ability of the bacilli to be reactivated after immune
suppression.3,33 This model can be used to fully charac-
terize the molecular markers of protective immunity and
reactivation. In addition, this model will be useful to study
the antibacterial activity of drugs during nonreplicating
persistence of Mtb.
After Mtb CDC1551 aerosol infection, we observed
early peaks in the proliferative capacity of CD4 and
CD8 T cells from the spleen (4 or 8 weeks p.i., respec-
tively), which declined rapidly, concurrent with a reduc-
tion in the bacillary load in the lungs. Similarly, IFN
expression in the infected lungs showed an early up-
regulation from 2 weeks p.i., returning to basal levels by
12 weeks. This pattern is in stark contrast to our obser-
vations in Mtb HN878-infected rabbits with chronic gran-
ulomatous TB, in which peak spleen CD4 and CD8
T-cell proliferative capacity was delayed (8 and 12
weeks, respectively) and then persisted at relatively high
levels.30 Interestingly, the T cells harvested from the
spleens of Mtb CDC1551-infected rabbits showed two
different phenotypes in ex vivo assays: cells proliferating
in the absence of exogenously added antigen and cells
proliferating in response to PPD or Mtb stimulation. This
observation suggests the presence of two populations in
vivo, which may represent effector (antigen-independent
ex vivo proliferation) and memory T cells (antigen-depen-
dent ex vivo proliferation).34 The antigen-independent
(putative effector) CD4 and CD8 T cells were found at
relatively high frequencies in the spleen during the first
few weeks of CDC1551 infection and, thereafter, de-
clined. The antigen-dependent T-cell population also
peaked early and then declined, but a small pool of these
cells appeared to persist after the clearance of cultivable
bacilli from the lungs, consistent with a memory T-cell
phenotype.35 This interpretation, however, remains to be
proved, because the immunological reagents necessary
to define subsets of effector and memory T cells in the
rabbit are not available. Despite the potential presence of
abundant B cells in the lungs, B-cell activation, as deter-
mined by PPD-specific IgG production, was also minimal
in CDC1551-infected rabbits, compared with levels seen
in rabbits with progressive cavitary TB after HN878 infec-
tion.30 However, because the reagent used to detect B
cells was not rabbit B-cell specific, it is possible that the
frequency of this cell population among the total lym-
phoid cells was overestimated. Taken together, our ob-
servations suggest that the magnitude of the acquired
immune response during both LTBI and chronic active
disease appears to track with the antigenic load.36,37
In most mouse strains, Mtb infection is chronic and the
bacilli are not cleared from the lungs. Thus, the sustained
T-cell activation in these animals, although essential to
stabilize the bacillary load in the lungs, is not associated
1720 Subbian et al
AJP November 2012, Vol. 181, No. 5Figure 4. Differential expression of host genes involved in macrophage activation (A and B) and fibrosis/tissue remodeling (C and D) networks in Mtb-infected
rabbit lungs. A: Intensity plot (heat map) of 25 significantly differentially expressed rabbit genes that constitute the macrophage activation network. The expression
values were arranged in a descending manner (from top to bottom) at 2 weeks. B: Interaction map of member genes of the macrophage activation network at
2 weeks p.i. C: Heat map of significantly differentially expressed rabbit genes involved in fibrosis and the tissue remodeling network in the lungs. The expression
values are sorted in a descending manner (from top to bottom) at 2 weeks. D: Interaction among the members of fibrosis and tissue remodeling network genes
at 2 weeks p.i. For A and C, the color scale ranges from 2 (up-regulated; red) to 2 (down-regulated; blue), and yellow indicates the absence or insignificant
expression of the gene. For B and D, green represents down-regulation; red, up-regulation; and no color, the absence or insignificant expression of the gene.
Intensity in the colors of gene symbols corresponds to their respective level of expression as numerically mentioned under each gene symbol. Values presented
are normalized to the level of expression observed in uninfected rabbit lungs.
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against TB). Rather, sustained T-cell activation is seen
with adaptation of the host immune response to chronic
antigenic stimulation.35,38 Our observations in the rabbit
LTBI model support a recently emerging idea that out-
come of Mtb infection is largely determined by the kinet-
ics of recruitment and activation of the lymphocytes in
response to Mtb infection, rather than simply the overall
numbers of T cells.39–42 Indeed, although CD4 T-cell–
deficient mice failed to control Mtb infection, later deple-
tion of the CD4 T cells in the antibiotic-dependent
mouse TB latency model (Cornell model) showed minimal
impact on bacillary control.43,44 In addition, during early
infection of nonhuman primates, anti-mycobacterial im-
munity was dependent on the presence of CD4 T cells,
whereas depletion of these cells in animals with LTBI had
less impact on Mtb control.45 In human studies, patients
with TB who had chronic disease displayed progressive
impairment of Mtb-specific T-cell responses with increas-
ing bacillary loads. In these patients, a reduction in the
relative numbers of polyfunctional CD4 T cells and in-
creased frequencies of CD8 T cells, compared with
individuals with LTBI, were seen.36 Moreover, in bacille
Calmette-Guérin–vaccinated neonates, we have shown
that the frequency of cytokine-producing T cells, includ-
ing both monofunctional and polyfunctional, does not
predict protection against progression of Mtb infection to
active disease.46,47
Macrophages play a central role in the host immune
response to Mtb infection.48,49 However, although opti-
mal macrophage activation and TNF- production are
Figure 5. Quantification of selected differentially expressed genes involved
in macrophage function and fibrosis/tissue remodeling during Mtb CDC1551
infection in rabbit lungs. The expression level of selected rabbit genes is
quantified by real-time qPCR, normalized against the housekeeping gene
GAPDH, and represented as relative fold compared with the expression
levels in uninfected, naïve rabbits. The expression level of each gene plotted
in the graph is median  SE, measured in triplicate reactions from at least
three different experiments. P  0.05 compared to uninfected for all genes
except TNFa and CAV1 at 8w and MMP14 at 12 weeks.essential for controlling the growth and/or killing of intra-cellular Mtb, overproduction or chronically elevated lev-
els of TNF- can lead to exacerbated inflammation and
tissue damage.50,51 Indeed, in rabbits with chronic
HN878 infection, in which macrophage activation and
TNF- production are sustained, extensive necrosis and
lung tissue damage are seen.30 In the rabbit model of
LTBI, we observed an early activation of macrophages
and increased TNF transcript levels in the lungs of in-
fected animals. This response was associated with the
control of growth and clearance of the bacilli and damp-
ened when the bacillary load was reduced. Conse-
quently, in the absence of elevated TNF levels, no ne-
crosis was seen in the evolving lung granulomas.
Moreover, once bacillary growth was controlled and the
frequency of macrophages producing TNF- in the
tissues declined, the chronic mononuclear leukocyte
inflammatory response, manifested as granulomas in
the lungs, resolved. Consistent with this finding, the
expression of the macrophage activation and inflam-
matory network genes, including TNF, was up-regu-
lated in the lungs during early infection and progres-
sively declined as the infection was controlled. In
contrast, the expression of TLR2 was up-regulated and
persisted until bacillary clearance was seen in the in-
fected rabbit lungs. TLR2 is expressed on cells of both
innate and adaptive immunity, plays a crucial role in
the recognition and killing of virulent Mtb strains, and is
essential to prevent progression of disease.52,53 In the
absence of TLR2, as seen in TLR2-deficient mice, un-
controlled lung bacillary growth, decreased immune
cell migration, and a defective granulomatous re-
sponse in the lungs were noted, resulting in exacer-
bated inflammation.54,55 Thus, the persistence of ele-
vated TLR2 in the CDC1551-infected rabbits may have
been associated with the bacillary clearance and lim-
ited pathological characteristics seen in the lungs. In
addition, we noted a significant down-regulation in the
transcript levels of IL-1, IL-8, and CCL2 in the Mtb-
infected rabbit lungs. These results are consistent with
reports describing elevated levels of these cytokines in
the blood of patients with active TB, compared with
uninfected and latently infected individuals.56,57
Chronic inflammation, such as seen during active pul-
monary TB, can drive granuloma enlargement and case-
ation, cavity formation, and fibrosis, involving extensive
fibroblast proliferation and collagen deposition around
the granulomas in the infected organs.29,58 Matrix metal-
loproteinases (MMPs), a family of proteases that includes
collagenase, esterase, and stromelysins, play a key role
in fibrosis, extracellular matrix destruction, and tissue
remodeling during progressive TB.58 More important,
TNF-, the most prominent inflammatory cytokine in-
volved in TB pathogenesis, regulates the expression of
several MMPs, and tissue inhibitor of MMP-1 (TIMP-1) is
a negative regulator of MMP-9.59,60 During CDC1551 in-
fection, we observed the down-regulation of several im-
portant fibrosis network genes, includingMMP9,MMP12,
MMP13, and MMP14, with concomitant up-regulation of
TIMP1 expression, together with a lack of fibrosis in the
lungs, as demonstrated by immunohistological analysis.
These results are consistent with observations of higher
Mtb HN878. The images were photographed. Original magnification: 10
(A); 40 (B and C).
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compared with uninfected individuals and the presence
of abundant MMP-9 levels found in multinucleated giant
cells surrounding the necrotic lesions of lymph node bi-
opsy specimens from patients with active TB.61,62 In our
rabbit model, SELE and SELP, which encode the E- and
L-selectin cell adhesion molecules, were moderately up-
regulated at 2 weeks and gradually down-regulated at
later times of infection, consistent with the absence of
active, progressive pathological characteristics in these
animals. In patients with active TB, levels of SELE and
SELP were elevated compared with uninfected control
subjects, and increased levels of serum E- and L-selec-
tins directly correlated with the severity of disease, as
determined by radiological diagnosis.63
Complete and spontaneous clearance of cultivable ba-
cilli from the infected lung is considered a hallmark of
LTBI in humans.64,65 In the mouse and guinea pig models
of Mtb infection, the bacteria are maintained at relatively
high numbers in the infected lungs, whereas in the rat
model, Mtb CFU numbers are reduced by the host im-
mune response, but the bacilli are not fully cleared.65,66
Anti-TB drug therapy must be administered to obtain full
clearance of cultivable Mtb from the lungs of these animal
species.22,23 Even in the rabbit, not all Mtb strains are
cleared spontaneously. Thus, the nature of the infecting
Mtb strain significantly affects the host-pathogen interac-
tions and determines the outcome of infection in these
and other animal species.14,67,68 Thus far, only Mtb
CDC1551 infection of rabbits has consistently resulted in
complete clearance of the bacilli from the lungs. Mtb
HN878 infection was not controlled by the rabbit immune
response.30 Although Mtb H37Rv numbers in rabbits
were reduced with time, the bacilli were not fully cleared,
even after 20 weeks of pulmonary infection.17,19,20,69,70
Multiple studies have focused on identifying the Mtb
genes and their products that determine whether the
bacilli can subvert the host immune response and con-
tinue growing, or whether they are controlled and
cleared.71,72 Prominent among the putative Mtb strain-
specific determinants are several lipids, which appear to
have immune-modulatory capabilities, suggesting that
such capacity may be an important feature of the suc-
cess of this pathogen in human populations.73–75 Ulti-
mately, an understanding of the host and pathogen fac-
tors that determine the outcome after Mtb infection,
whether individuals develop active infectious TB or LTBI,
will facilitate the development of better intervention for
improved TB control.
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